ShareValue scores for CARL: Valuation 47, Quality 53, Growth 58, Health 45.

Carlsmed, Inc. Common Stock logo

CARL
NASDAQ

Carlsmed, Inc. Common Stock

$13.70(+1.03%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
47
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
58
Moderate
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
29
Bearish
Price Trend

Company Details

About

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026